Naturopathic-pharmacological Consultation in Hematology

Status Recruiting

Clinical Trial Summary

The goal of this cross-sectional study is to learn about the effect of a naturopathic-pharmacologic consultation in patients with hematologic conditions. The main question it aims to answer is whether such consultation can improve the safety of dietary and herbal supplements' use among these patients. Participants will be asked to answer basic questions and fill-out questionnaire before and after meeting the consultation team. Some patients will be prescribed dietary and herbal supplements that may help relief some of the symptoms they describe, in a safe way and without interacting with the drugs they are taking.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Hematologic Diseases

Clinical Trial Details

NCT number	NCT05982262
Study type	Interventional
Source	Bnai Zion Medical Center
Contact	Dana Weizer
Phone	972543295952
Email	dana.weizer@b-zion.org.il
Status	Recruiting
Phase	N/A
Start date	June 15, 2023
Completion date	June 2028

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04094844` - Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation	N/A
Completed	`NCT04474678` - Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")	N/A
Recruiting	`NCT03918343` - Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation	N/A
Completed	`NCT01445561` - Ultra Low Dose Interleukin-2 in Healthy Volunteers	Phase 1
Recruiting	`NCT06148610` - Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
Completed	`NCT04168983` - Impact of Sophrology on the Pain Felt During a Bone Marrow Aspiration and Biopsy	N/A
Not yet recruiting	`NCT05969821` - Clonal Hematopoiesis of Immunological Significance
Withdrawn	`NCT04282174` - CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies	Phase 2
Completed	`NCT01108159` - Integrated Whole-Genome Analysis of Hematologic Disorders
Completed	`NCT00800839` - Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide	Phase 2
Completed	`NCT00213239` - A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children	Phase 1/Phase 2
Terminated	`NCT00208949` - A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF	Phase 2
Terminated	`NCT00176826` - T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders	Phase 2/Phase 3
Completed	`NCT00208962` - Allogeneic Cell Therapy for Adults With Hematologic Malignancies	Phase 2
Completed	`NCT00000603` - Cord Blood Stem Cell Transplantation Study (COBLT)	Phase 2
Completed	`NCT00000587` - Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection	Phase 2
Active, not recruiting	`NCT03655678` - A Safety and Efficacy Study Evaluating CTX001 in Subjects With Transfusion-Dependent β-Thalassemia	Phase 2/Phase 3
Recruiting	`NCT05487794` - Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men With Erythrocytosis	N/A
Completed	`NCT03611257` - Effect of dRAST on Treatment for Bacteremia in Patients With Hematologic Diseases	N/A
Completed	`NCT02827149` - High Resolution Donor Recipient HLA Matching Level in Unrelated HSCT